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Conclusion: The γmean, γmedian and γ1% metrics have 
potential to be used as parameters to predict PTV dose 
deviations and had better correlation than the passing rate. 
However for OAR dose deviations, the γmax showed the 
strongest correlation with DVH deviations. This methodology 
is robust the variability in γ calculation. 
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Purpose or Objective: Aim of this study is the evaluation of 
build-up and superficial doses for a Head&Neck treatment, 
delivered by Helical TomoTherapy (HT). Measurements were 
carried out by two different dosimeters (radiochromic films 
and a synthetic single crystal diamond detector) and 
compared with TPS data. Build-up dose profiles and 
superficial dose points were estimated. The reliability of the 
TPS in these critical regions was assessed, giving an insight 
into a subject on which quite contradictory results are 
reported in the literature. 
 
Material and Methods: A home modified Anderson Rando 
phantom was employed to house the detectors. As shown in 
figure (a), two slices of the phantom neck were removed and 
replaced with a PMMA artificial neck, with a hole inside to 
mimic the trachea. This allowed to measure dose profiles and 
superficial dose points with geometrical and scattering 
conditions similar to the ones taking place when a real 
patient is treated. Gafchromic EBT3 films (Ashland Inc., 
Wayne, NJ) were sandwiched inside the neck in oder to 
measure dose profiles and attached to the neck surface for 
superficial dose point assessment. PTW-Frieburg 
microDiamond (mD) was positioned inside drilled holes at 
different known distances respect to the phantom surface.  
 
 
 
Results: In figure (b) one of the measured dose profiles by 
EBT3 and mD is reported, along the Antero-Posterior 
direction, in the range 0-30 mm (distance from the phantom 
surface). TPS data are also shown, as black dots, with an 
associated error of ± 0.9 mm, half of the lateral dimension of 
the calculation pixel (fine grid). The prescribed dose is 
reached within approximately 4 mm from the phantom 
surface and it does not show any significant variation going 
further inside the neck, in particular at the PMMA/air 
interface, in correspondence of the trachea starting point. 
A 1D threshold criterion of 3%/mm was adopted in order to 
discriminate between high and low gradient zones. Dose 
differences (DD) measured by mD are within 2.5% respect to 
TPS, in the low gradient region, while a maximum distance-
to-agreement (DTA) of 0.9 mm is found for the same device, 
in the high gradient region. EBT3 profile shows a more noisy 
behavior, with a maximum DD of 3.8% in the low gradient 
portion of the profile, while DTA is less than 1 mm in the high 
gradient zone. The superficial dose measurement by EBT3 
film is characterized by a DTA of 0.5 mm and a DD of 5.2%.  
 
Conclusion: Build-up dose profiles measured by the two 
dosimeters show the same behavior and are in agreement 
with TPS data; deviations are well within the reference 
tolerance level. The investigation carried out in this work 
offers the possibility of studying the TPS behavior not only in 
terms of dose difference, as carried out for in vivo 
measurements, but also taking into account a “spatial 
displacement”, to be compared with patient (and/or 
dosimeter) positioning uncertainties. 
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Purpose or Objective: To evaluate experimentally the 
accuracy of the dose calculation algorithm AcurosXB in small-
field highly modulated Volumetric Modulated Arc Therapy 
(VMAT). 
 
Material and Methods: The Octavius 1000SRS detector array 
inserted in the rotational Octavius4D phantom (PTW) was 
used, consisting of 977 liquid-filled ion chambers covering an 
area of 11×11cm2. The detector size (2.3×2.3×0.5mm3) and 
the center-to-center distance of the detectors (2.5mm in the 
inner 5.5×5.5cm2 area) are important parameters for correct 
spatial measurement of complex dose distributions with 
steep dose gradients. Clinical treatment plans (n=28), 
characterized by small treatment volumes, 6 and 10MV 
photon beams, and fraction doses between 2.75-30 Gy, were 
projected on the phantom CT data set and recalculated in 
the Eclipse TPS v11 (Varian Medical Systems) using AcurosXB 
with a calculation grid size of 2.5mm and 1mm (field sizes 
<3x3cm2). All measurements were done on a Varian 
TrueBeamSTx linac. The irradiation technique used was 
